pCEP4-BG505.DS-SOSIP.6mut-gp160
(Plasmid
#123278)
-
PurposeMammalian expression plasmid for Env from the BG505 HIV-1 isolate; DS-SOSIP.6mut variant
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 123278 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCEP4
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 10393
- Total vector size (bp) 12758
-
Vector typeMammalian Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHIV-1 (BG505) Env
-
Alt namegp160
-
Alt nameEnv
-
SpeciesHuman immunodeficiency virus 1
-
Insert Size (bp)2583
-
MutationCodon-optimized synthetic gene; SOSIP mutations; Mutations L154M, Y177W, I201C, N300M, N302M, T320L, I420M, A433C
-
GenBank IDABA61516.1
- Promoter CMV
-
Tag
/ Fusion Protein
- CD5 leader peptide (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CMV_fwd
- 3′ sequencing primer EBV_rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCEP4-BG505.DS-SOSIP.6mut-gp160 was a gift from Erik Procko (Addgene plasmid # 123278 ; http://n2t.net/addgene:123278 ; RRID:Addgene_123278) -
For your References section:
Conformational engineering of HIV-1 Env based on mutational tolerance in the CD4 and PG16 bound states. Heredia JD, Park J, Choi H, Gill KS, Procko E. J Virol. 2019 Mar 20. pii: JVI.00219-19. doi: 10.1128/JVI.00219-19. 10.1128/JVI.00219-19 PubMed 30894475